Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study - Van den Bent, Martin J.; Wick, Wolfgang (The lancet, 2017)
Published online August 8, 2017